ライフサイエンスコーパス: leukemia virus

1 RNAs packaged by a model retrovirus, murine leukemia virus.

2 ation and packaging domain of Moloney murine leukemia virus.

3 those of oncoretroviral RTs, such as murine leukemia virus.

4 h the amphotropic envelope protein of murine leukemia virus.

5 ), simian immunodeficiency virus, and murine leukemia virus.

6 fection of one cell line (DEL) with a murine leukemia virus.

7 The etiology of human T cell leukemia virus 1 (HTLV-1)-mediated adult T cell leukemia

8 proviral integration site for Moloney murine leukemia virus 1 kinase (PIM-1).

9 etradecanoylphorbol-13-acetate, human T-cell leukemia virus 1 Tax, and CD40 did not.

10 Proviral Integration site for Moloney murine leukemia virus 1) has emerged as a key regulator of hypo

11 Ectopic expression of human T cell leukemia virus 1-encoded Tax protein, which resembles K1

12 bly myelopathy induced by retrovirus human T leukemia virus-1 (HTLV-1).

13 proviral integration site for Moloney murine leukemia virus-1 (PIM-1), which in turn regulates NFkapp

14 zes the foreign Ag Tax from the human T cell leukemia virus-1 when presented by the class I MHC HLA-A

15 ink with the autoimmune disease human T cell leukemia virus-1-associated myelopathy/tropical spastic

16 reported that ectopic expression of Moloney leukemia virus 10 (MOV10) protein strongly inhibits retr

17 Moloney leukemia virus 10, homolog (MOV10) is an IFN-inducible R

18 The Abelson murine leukemia virus (A-MuLV) expresses an alternative form of

19 A recent demonstration that the bovine leukemia virus, a retrovirus, uses RNA polymerase III to

20 in tyrosine kinase encoded by Abelson murine leukemia virus (Ab-MLV) transforms pre-B cells.

21 ipeline, can identify integrations of murine leukemia virus, adeno-associated virus, Tol2 transposons

22 ar to canonical retroviruses, such as murine leukemia virus and HIV.

23 livery by wild-type ecotropic Moloney murine leukemia virus and vesicular stomatitis virus (VSV) G gl

24 to what extent virions of HERV-Kcon, murine leukemia virus, and HIV-1 have the ability to transduce

25 rived from three retroviruses (HIV-1, murine leukemia virus, and Mason-Pfizer monkey virus), two hepa

26 es blocked cytokine induction by HIV, murine leukemia virus, and simian immunodeficiency virus.

27 plication method for the detection of bovine leukemia virus antigen gp51.

28 The integration pattern of murine leukemia virus appears to be largely driven by regions t

29 V and the intensively studied Moloney murine leukemia virus, architectures of the regulatory domains

30 immunodeficiency (SCID-X1), a Moloney murine leukemia virus-based gamma-retrovirus vector expressing

31 virus infections: sheep infected with Bovine Leukemia Virus (BLV) and humans infected with Human T Ly

32 In contrast, bovine leukemia virus (BLV) expresses subgenomic RNAP III trans

33 arged residues in the deltaretrovirus bovine leukemia virus (BLV) matrix (MA) and NC domains affects

34 Here we demonstrate that the bovine leukemia virus (BLV), a retrovirus with an RNA genome, e

35 est that the leader region of Moloney murine leukemia virus contains inhibitory/regulatory sequences,

36 by reverse transcription via Moloney murine leukemia virus, degradation of chromosomal DNA with McrB

37 as the proto-oncogene from which the Abelson leukemia virus derived its Gag-v-Abl oncogene, recent re

38 uences in the 3' U3 region of Moloney murine leukemia virus-derived retroviral vectors.

39 EC3 does not catalyze base changes in murine leukemia virus DNA, it can be recovered from these virus

40 idly loaded onto unintegrated Moloney murine leukemia virus DNAs.

41 iple clonal integrations of ecotropic murine leukemia virus (E-MuLV).

42 Ecotropic, xenotropic, and polytropic mouse leukemia viruses (E-, X-, and P-MLVs) exist in mice as i

43 Murine leukemia viruses encode a unique form of Gag polyprotein

44 his hypothesis, infection of HIV-1 or murine leukemia virus Env (MLV-Env)-pseudotyped HIV-1 particles

45 defect in proteolytic cleavage of the murine leukemia virus Env cytoplasmic tail in pseudotyped virio

46 HIV-1, vesicular stomatitis virus, or murine leukemia virus Env glycoproteins.

47 The trimeric Moloney murine leukemia virus Env protein matures by two proteolytic cl

48 The membrane-proximal region of murine leukemia virus envelope (Env) is a critical modulator of

49 viral glycoproteins, including Friend murine leukemia virus envelope (F-MLV Env) are actively recruit

50 etherin and a viral glycoprotein, gibbon ape leukemia virus envelope (GaLV Env).

51 For murine leukemia virus envelope (MLV Env) glycoprotein, incorpor

52 For murine leukemia virus envelope (MLV Env) glycoprotein, incorpor

53 ing sequence of the ecotropic Moloney murine leukemia virus envelope glycoprotein with the peptide li

54 d how the protomeric units of Moloney murine leukemia virus envelope protein (Env) are activated in r

55 rovirus glycoproteins, such as Friend murine leukemia virus (F-MLV) Env, but not with the related gib

56 e envelope glycoprotein of the Friend murine leukemia virus (F-MLV) ISD has been reported to abolish

57 Feline leukemia virus (FeLV) is a naturally transmitted gammare

58 Feline leukemia virus (FeLV) is still a major cause of morbidit

59 exposure to gammaretroviruses such as feline leukemia viruses (FeLVs) occurs worldwide, but the basis

60 uses that infect human cells in vitro Feline leukemia viruses (FeLVs) rank high on this list, but nei

61 serted at random positions throughout murine leukemia virus Gag-Pol, then selecting for variants that

62 Gibbon ape leukemia virus (GALV) and koala retrovirus (KoRV) most l

63 Gibbon ape leukemia virus (GALV) and the koala retrovirus (KoRV) ar

64 LV) Env, but not with the related gibbon ape leukemia virus (GaLV) Env or with a chimeric F-MLV Env w

65 The Env protein from gibbon ape leukemia virus (GaLV) has been shown to be incompatible

66 etrovirus-related virus (XMRV) or gibbon ape leukemia virus (GALV) infection, even when their respect

67 The gibbon ape leukemia viruses (GALVs) are among the most medically re

68 Gibbon ape leukemia viruses (GALVs) are part of a larger group of p

69 e shown to restrict the expression of murine leukemia virus genomes but not retroviral genomes of the

70 parental wild-type ecotropic Moloney murine leukemia virus glycoprotein through the ecotropic recept

71 variants to promote the modified gibbon ape leukemia virus glycoprotein-pseudotyped lentiviral vecto

72 coproteins and also with modified gibbon ape leukemia virus glycoproteins.

73 Human T-cell leukemia virus (HTLV) type 1, the etiological agent of a

74 overed the antisense protein of human T-cell leukemia virus (HTLV) type 2 (APH-2), whose messenger RN

75 ly linked to infection with the human T-cell leukemia virus (HTLV-1).

76 and partial characterization of human T-cell leukemia virus (HTLV; now known as HTLV-1) produced by a

77 , human immunodeficiency virus, human T cell leukemia virus, human papilloma virus, hepatitis B and C

78 ic resonance structure of the Moloney murine leukemia virus IN (M-MLV) C-terminal domain (CTD) and a

79 lly infected with the gammaretrovirus murine leukemia virus in which receptor has been downregulated,

80 SRP1 reduces HIV-1 infection, but not Murine Leukemia Virus, in human CD4(+) T cells.

81 In murine leukemia virus-induced myeloid leukemia in mice, integra

82 Infection with human T-cell leukemia virus induces cellular genomic instability medi

83 We found a previously unknown murine leukemia virus infection in one cell line.

84 The B-lymphoma Moloney murine leukemia virus insertion region-1 protein (BMI1) acts as

85 bidopsis thaliana) B lymphoma Moloney murine leukemia virus insertion region1 homolog (BMI1) POLYCOMB

86 The ETS factor Friend leukemia virus integration 1 (FLI1) is a key modulator o

87 Friend leukemia virus integration 1 (FLI1), a critical transcri

88 Friend leukemia virus integration 1 (FLI1), an Ets transcriptio

89 TSA also restored Friend leukemia virus integration 1, an inhibitor of the type I

90 B-cell-specific Moloney murine leukemia virus integration site 1 (BMI1) is a component

91 We generated murine leukemia virus integrations in human HepG2 and K562 cell

92 Injection of the LP-BM5 murine leukemia virus into mice causes murine AIDS, a disease c

93 some conservation between murine and feline leukemia viruses is crucial for activity.

94 Replication of the murine leukemia viruses is strongly suppressed in mouse embryon

95 of proviral insertion site of Moloney murine leukemia virus kinases (Pim-1, -2, and -3) in cancers, p

96 d thrombopoietin/cellular myeloproliferative leukemia virus liganding is dispensable for definitive t

97 Moloney murine leukemia virus-like particles (M-VLPs) were complexed wi

98 Non-infectious murine leukemia virus-like particles (M-VLPs) were electrostati

99 essive mutation (Lamc2(jeb)) due to a murine leukemia virus long terminal repeat insertion in Lamc2 (

100 In the case of the ecotropic Moloney murine leukemia virus (M-MLV), the Nef-like effect is mediated

101 r80gag facilitates release of Moloney murine leukemia virus (M-MuLV) from cells along an IFN-sensitiv

102 The Env protein of murine leukemia virus matures by two cleavage events.

103 Bovine leukemia virus microRNAs are strongly expressed in prele

104 dispensable for in vivo infectivity, bovine leukemia virus microRNAs represent approximately 40% of

105 release of HIV-1, as well as that of murine leukemia virus (MLV) and Ebola virus (EBOV); knockdown o

106 We demonstrate that murine leukemia virus (MLV) and human immunodeficiency virus (H

107 gene of gammaretroviruses, including murine leukemia virus (MLV) and xenotropic murine leukemia viru

108 Using the murine leukemia virus (MLV) as a model retrovirus, we have prev

109 Remarkably, although Moloney leukemia virus (MLV) assembles in the cytoplasm, precurs

110 nvelope protein (Env) from the CasBrE murine leukemia virus (MLV) can cause acute spongiform neurodeg

111 Murine leukemia virus (MLV) can efficiently spread in tissue cu

112 eins previously identified to inhibit murine leukemia virus (MLV) demonstrated an ability to induce N

113 gamma-Retroviral murine leukemia virus (MLV) DNA integration into the host genom

114 p between two recent additions to the murine leukemia virus (MLV) ecotropic subgroup: Mus cervicolor

115 The glycoprotein murine leukemia virus (MLV) Env can readily form pseudotyped pa

116 infectivity of HIV-1 pseudotyped with murine leukemia virus (MLV) Env was not affected by Vpu.

117 generated chimeric constructs between murine leukemia virus (MLV) Gag and HBV Core to determine if th

118 The p12 protein of murine leukemia virus (MLV) Gag is associated with the preinteg

119 Here, we show that murine leukemia virus (MLV) has a unique means of counteracting

120 Murine leukemia virus (MLV) has been studied as one of the clas

121 eping Beauty (SB) transposons and the murine leukemia virus (MLV) in mouse embryonic stem cells (ESCs

122 ptide sequence from the C terminus of murine leukemia virus (MLV) IN.

123 We report alterations to the murine leukemia virus (MLV) integrase (IN) protein that success

124 rstanding the molecular mechanisms of murine leukemia virus (MLV) integration into host chromatin is

125 nd that the preintegration complex of murine leukemia virus (MLV) interacts with the dynein complex a

126 Murine leukemia virus (MLV) p12, encoded within Gag, binds the

127 ron-alpha-responsive manner, captures murine leukemia virus (MLV) particles and mediates their transf

128 iciencies of restriction of HIV-1 and murine leukemia virus (MLV) particles containing various propor

129 ious anemia virus (EIAV), or N-tropic murine leukemia virus (MLV) postentry and supported late HIV-1

130 era, each prepared against a purified murine leukemia virus (MLV) protein.

131 cosylated Gag (glycoGag) protein of a murine leukemia virus (MLV) similarly enhance the infectiousnes

132 , we engineered a fluorescent Moloney murine leukemia virus (MLV) system consisting of MLV-integrase

133 Using a murine leukemia virus (MLV) variant with an unstable capsid tha

134 ement of the photonic inactivation of Murine Leukemia Virus (MLV) via 805 nm femtosecond pulses throu

135 ection by the gammaretrovirus Moloney murine leukemia virus (MLV) was unaffected.

136 perties of the Gag protein of Moloney murine leukemia virus (MLV), a gammaretrovirus.

137 vectors bearing the envelope of 10A1 murine leukemia virus (MLV), a murine retrovirus that can use P

138 For retroviruses such as HIV-1 and murine leukemia virus (MLV), active receptor recruitment and tr

139 simian immunodeficiency virus (SIV), murine leukemia virus (MLV), and the retrotransposon MusD.

140 domains in gammaretroviruses, such as murine leukemia virus (MLV), is unique.

141 For simple retroviruses, such as murine leukemia virus (MLV), the identities of the cellular pro

142 We developed a Moloney mouse leukemia virus (MLV)-based retroviral replicating vector

143 ary human CD4(+) T lymphocytes with a murine leukemia virus (MLV)-based retroviral vector or xenotrop

144 n the long terminal repeats (LTRs) of murine leukemia virus (MLV)-based vectors and the vector-specif

145 therapy approaches utilize HIV-1- or murine leukemia virus (MLV)-based vectors, which preferentially

146 odeficiency virus type 1 (HIV-1)- and murine leukemia virus (MLV)-derived viral vectors, respectively

147 e a newly appreciated viral target in murine leukemia virus (MLV)-induced neurodegeneration.

148 The association of xenotropic murine leukemia virus (MLV)-related virus (XMRV) in prostate ca

149 related virus (XMRV) as well as other murine leukemia virus (MLV)-related viruses, though not all stu

150 to support the replication of Moloney murine leukemia virus (MLV).

151 T lymphocytes are natural targets of murine leukemia virus (MLV).

152 monkey virus (M-PMV) but not Moloney murine leukemia virus (MLV).

153 Certain murine leukemia viruses (MLVs) are capable of inducing fatal pr

154 Mouse leukemia viruses (MLVs) are found in the common inbred s

155 Many murine leukemia viruses (MLVs) are partially resistant to restr

156 Laboratory mice carry mouse leukemia viruses (MLVs) of three host range groups which

157 irus-induced leukemogenesis, ecotropic mouse leukemia viruses (MLVs) recombine with nonecotropic endo

158 Murine leukemia viruses (MLVs), including xenotropic-MLV-relate

159 ers of the gammaretroviruses--such as murine leukemia viruses (MLVs), most notably XMRV [xenotropic m

160 An RNA kissing loop from the Moloney murine leukemia virus (MMLV) exhibits unusual mechanical stabil

161 y inhibits the replication of Moloney murine leukemia virus (Mo-MLV) and is required for the antiretr

162 L complex to newly integrated Moloney murine leukemia virus (Mo-MuLV) proviral DNA.

163 prototypical gammaretrovirus Moloney murine leukemia virus (MoMLV) favors strong enhancers and activ

164 reverse transcriptase (RT) of Moloney murine leukemia virus (MoMLV) is expressed in the form of a lar

165 The Moloney murine leukemia virus (MoMLV) ribonucleoprotein complex is comp

166 t not the RNase H function of Moloney Murine Leukemia Virus (MoMLV) RT and also inhibited Escherichia

167 that tetherin does not affect Moloney murine leukemia virus (MoMLV) spread, and only minimally affect

168 What role does myeloproliferative leukemia virus (MPL), a key regulator of adult megakaryo

169 calreticulin (CALR), and myeloproliferative leukemia virus (MPL), abnormally activate the cytokine r

170 gainst clade C HIV-1 gp140, gp120, or murine leukemia virus (MuLV) gp70-scaffolded V1/V2 and toward b

171 The p12 protein of murine leukemia virus (MuLV) group-specific antigen (Gag) is as

172 arce, femtomole quantities of Moloney murine leukemia virus (MuLV) RNA inside authentic virions and f

173 0.25 mM) and is comparable to Moloney murine leukemia virus (MuLV) RT fidelity.

174 High expression of murine leukemia virus (MuLV) transcripts was observed in DEL ce

175 mouse mammary tumor virus (MMTV) and murine leukemia virus (MuLV) via an adaptive immune mechanism,

176 ammaretroviruses, typified by Moloney murine leukemia virus (MuLV), gag and pol are in the same readi

177 rus 1 (Bxv1), a xenotropic endogenous murine leukemia virus (MuLV), is present in these 2 recently de

178 wild-type (WT) or Mll-AF9 mice with a murine leukemia virus (MuLV).

179 found to also contain reads from the murine leukemia virus (MuLV).

180 the mechanism of APOBEC inhibition of murine leukemia viruses (MuLVs) does not appear to be G-->A hyp

181 with mixtures of mouse retroviruses (murine leukemia viruses [MuLVs]) exhibit dramatically altered p

182 For the restriction of N-tropic murine leukemia virus (N-MLV) and equine infectious anemia viru

183 , we had previously selected N-tropic murine leukemia virus (N-MLV) mutants escaping from rhesus maca

184 man TRIM5alpha inhibition of N-tropic murine leukemia virus (N-MLV).

185 Calreticulin (CALR) and myeloproliferative leukemia virus oncogene (MPL) mutations are specific to

186 calreticulin (CALR), and myeloproliferative leukemia virus oncogene (MPL) mutations; respective freq

187 ng via the thrombopoietin/myeloproliferative leukemia virus oncogene (MPL) pathway and impaired propl

188 cellular homologue of the myeloproliferative leukemia virus oncogene (Mpl), is the major cytokine reg

189 LNK deficiency increases myeloproliferative leukemia virus oncogene signaling and AKT activation, wh

190 t promotes thrombopoietin/myeloproliferative leukemia virus oncogene signaling and platelet and leuko

191 NK function and increased myeloproliferative leukemia virus oncogene signaling.

192 , including JAK2 exon 12, myeloproliferative leukemia virus oncogene, LNK (also known as SH2B3) mutat

193 The myeloproliferative leukemia virus oncogene, MPL, a homodimeric receptor act

194 ignaling via its receptor myeloproliferative leukemia virus oncogene.

195 hibits the replication of HIV but not murine leukemia virus or chikungunya virus.

196 oad windows of small RNA sizes in the bovine leukemia virus ovine model of leukemia/lymphoma, we prov

197 provirus integration site for Moloney murine leukemia virus (Pim) 1 kinase is an oncogenic serine/thr

198 Proviral integration site for Moloney murine leukemia virus (Pim) kinases are serine/threonine/tyrosi

199 proviral integration site for Moloney murine leukemia virus (PIM) kinases PIM1 and PIM2 have been imp

200 al infection of rats with the PVC-211 murine leukemia virus (PVC-211 MuLV) and its underlying mechani

201 ugh active heme export by the group C feline leukemia virus receptor (FLVCR).

202 S has been associated with xenotropic murine leukemia virus-related virus (XMRV) as well as other mur

203 Xenotropic murine leukemia virus-related virus (XMRV) has been found in th

204 Although xenotropic murine leukemia virus-related virus (XMRV) has been previously

205 The discovery of xenotropic murine leukemia virus-related virus (XMRV) in human tissue samp

206 tudy identified DNA from a xenotropic murine leukemia virus-related virus (XMRV) in peripheral blood

207 Xenotropic murine leukemia virus-related virus (XMRV) infection was incorr

208 We analyzed xenotropic murine leukemia virus-related virus (XMRV) integration site seq

209 Xenotropic murine leukemia virus-related virus (XMRV) is a gammaretrovirus

210 Xenotropic murine leukemia virus-related virus (XMRV) is a gammaretrovirus

211 Xenotropic murine leukemia virus-related virus (XMRV) is a gammaretrovirus

212 Xenotropic murine leukemia virus-related virus (XMRV) was first identified

213 Xenotropic murine leukemia virus-related virus (XMRV) was previously repor

214 irus type-1 (HIV-1) and of xenotropic murine leukemia virus-related virus (XMRV), a gammaretrovirus t

215 based retroviral vector or xenotropic murine leukemia virus-related virus (XMRV), and isolated 32,585

216 A novel gammaretrovirus, xenotropic murine leukemia virus-related virus (XMRV), has been identified

217 identified retrovirus-the xenotropic murine leukemia virus-related virus (XMRV)-has recently been sh

218 thentic genomic RNA of the xenotropic murine leukemia virus-related virus (XMRV).

219 the human retrovirus XMRV (xenotropic murine leukemia virus-related virus) can induce rare foci of tr

220 The retrovirus XMRV (xenotropic murine leukemia virus-related virus) has been detected in human

221 retrovirus, termed "XMRV" (xenotropic murine leukemia virus-related virus) in prostate cancers (PCa).

222 a retrovirus called XMRV (xenotropic murine leukemia virus-related virus) was present in the blood o

223 istance of several commercial Moloney murine leukemia virus reverse transcriptase (MMLV RT) enzymes w

224 These compounds also inhibit Moloney murine leukemia virus RT but not the Klenow fragment of Escheri

225 Avian myeloblastosis and Moloney murine leukemia virus RTs also bound more stably to RNA-DNA, bu

226 cation in vivo, I constructed a novel murine leukemia virus strain (FMLV-IL-1beta) that encodes the m

227 ngle-nucleotide coding variant in the feline leukemia virus subgroup C cellular receptor 1 (FLVCR1),

228 Feline leukemia virus subgroup C cellular receptor 1a (FLVCR1a)

229 The feline leukemia virus subgroup C receptor (FLVCR) is a 12-trans

230 et al. reveal that an isoform of the feline leukemia virus subgroup C receptor (FLVCR1) exports heme

231 mRNA expression of the heme exporter feline leukemia virus subgroup C receptor 1 (beta = -0.30; P =

232 Feline leukemia virus subgroup C receptor 1 (FLVCR1) is a cell

233 Using Abelson murine leukemia virus-transformed B cells to model this stage o

234 during clonal expansion using Abelson murine leukemia virus-transformed B cells.

235 portant human pathogens such as human T-cell leukemia virus type 1 (HTLV-1) and HIV-1.

236 Human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2 are closely re

237 chniques in real time with both human T-cell leukemia virus type 1 (HTLV-1) and human immunodeficienc

238 Human T-cell leukemia virus type 1 (HTLV-1) and type 2 (HTLV-2) are h

239 Human T-cell leukemia virus type 1 (HTLV-1) and type 2 (HTLV-2) are h

240 report that vaccination against human T-cell leukemia virus type 1 (HTLV-1) basic leucine zipper (bZI

241 Infection with human T-cell leukemia virus type 1 (HTLV-1) can cause a rare form of

242 Infection by human T cell leukemia virus type 1 (HTLV-1) causes a fatal hematopoie

243 tegrated form of the retrovirus human T-cell leukemia virus type 1 (HTLV-1) contains identical DNA se

244 osed a model for this region of human T-cell leukemia virus type 1 (HTLV-1) Env in which expulsion of

245 Human T-cell leukemia virus type 1 (HTLV-1) establishes a lifelong in

246 Human T-cell leukemia virus type 1 (HTLV-1) expression depends on the

247 Human T-cell leukemia virus type 1 (HTLV-1) has two late domain (LD)

248 Human T-cell leukemia virus type 1 (HTLV-1) infection and transformat

249 Human T cell leukemia virus type 1 (HTLV-1) inhibits host antiviral s

250 Human T-cell leukemia virus type 1 (HTLV-1) is a complex retrovirus a

251 Human T-cell leukemia virus type 1 (HTLV-1) is a retrovirus, and, as

252 Human T-cell leukemia virus type 1 (HTLV-1) is an oncogenic retroviru

253 Human T cell leukemia virus type 1 (HTLV-1) is associated with two im

254 The particle structure of human T-cell leukemia virus type 1 (HTLV-1) is poorly characterized.

255 Human T-cell leukemia virus type 1 (HTLV-1) is the causative agent of

256 Human T-cell leukemia virus type 1 (HTLV-1) is the causative agent of

257 The complex retrovirus human T-cell leukemia virus type 1 (HTLV-1) is the causative agent of

258 Human T-cell leukemia virus type 1 (HTLV-1) is the etiological agent

259 kawa et al demonstrate that the human T-cell leukemia virus type 1 (HTLV-1) oncoprotein Tax induces a

260 present study, we show that the Human T-cell Leukemia Virus Type 1 (HTLV-1) oncoprotein Tax is a subs

261 d to be largely dispensable for human T-cell leukemia virus type 1 (HTLV-1) particle biogenesis.

262 The role of autophagy in human T-cell leukemia virus type 1 (HTLV-1) replication has, however,

263 Human T-cell leukemia virus type 1 (HTLV-1) Tax affects cellular geno

264 The human T-cell leukemia virus type 1 (HTLV-1) Tax oncoprotein actively

265 t of humanized mice infected by human T-cell leukemia virus type 1 (HTLV-1) that recapitulate adult T

266 The glycoproteins from human T-cell leukemia virus type 1 (HTLV-1) were resistant to the ant

267 In comparison, NC of human T-cell leukemia virus type 1 (HTLV-1), a deltaretrovirus, displ

268 Human T cell leukemia virus type 1 (HTLV-1), also known as human T ly

269 retroviral oncoprotein Tax from human T-cell leukemia virus type 1 (HTLV-1), an etiological factor th

270 found that HBZ, encoded by the Human T-cell Leukemia Virus type 1 (HTLV-1), binds to multiple domain

271 on by HIV-1, HIV-1Deltavif, and human T-cell leukemia virus type 1 (HTLV-1), while significantly inhi

272 ptosis, we used TRAIL-resistant human T cell leukemia virus type 1 (HTLV-1)-associated adult T cell l

273 Human T-cell leukemia virus type 1 (HTLV-1)-associated adult T-cell l

274 to the total viral burden in 22 human T cell leukemia virus type 1 (HTLV-1)-infected individuals by a

275 Disease development in human T-cell leukemia virus type 1 (HTLV-1)-infected individuals is p

276 ion with the complex retrovirus human T-cell leukemia virus type 1 (HTLV-1).

277 ive T-cell malignancy caused by human T-cell leukemia virus type 1 (HTLV-1).

278 Human T-cell leukemia virus type 1 (HTLV-I) is associated with adult

279 of BIC by up to 70% in EBV- or human T-cell leukemia virus type 1 (HTLV1)-transformed cell lines and

280 Human T cell leukemia virus type 1 and type 2 (HTLV-1 and -2) are two

281 Tax oncoprotein encoded by the human T-cell leukemia virus type 1 plays a pivotal role in viral pers

282 Human T-cell leukemia virus type 1-associated adult T-cell leukemia/l

283 Human T-cell leukemia virus type 1-infected cells proliferate faster

284 Moloney leukemia virus type 10 protein (MOV10) is an RNA helicas

285 s in the transplant population: human T-cell leukemia virus type 1; hepatitis E virus; bocavirus; KI

286 Human T-cell leukemia virus type I (HTLV-1) replication relies on the

287 The Human T-cell leukemia virus type I (HTLV-I) is the only known transfo

288 osomal templates containing the human T-cell leukemia virus type-1 promoter sequences.

289 Human T cell leukemia virus, type 1 (HTLV-1) replication and spread a

290 Human T-cell leukemia virus types 3 and 4 (HTLV-3 and HTLV-4) are rec

291 reased by 3- to 5-fold by placing the murine leukemia virus UAG read-through element upstream of the

292 Stavrou et al. (2015) reveal how the murine leukemia virus uses a sugar-protein shield to protect fr

293 TM cleavage in Moloney murine leukemia virus was inhibited by amprenavir, and the Envs

294 with the C terminus of Tax-1 of human T-cell leukemia virus with micromolar affinity.

295 e APOBEC3 protein blocks infection by murine leukemia viruses without catalyzing this base change, an

296 nonpermissive to XMRV and xenotropic murine leukemia virus (X-MLV) infection, suggesting that the xe

297 (MLVs), most notably XMRV [xenotropic murine leukemia virus (X-MLV)-related virus--have been reported

298 The xenotropic and polytropic mouse leukemia viruses (X-MLVs and P-MLVs, respectively) have

299 Xenotropic mouse leukemia viruses (X-MLVs) are broadly infectious for mam

300 e leukemia virus (MLV) and xenotropic murine leukemia virus (XMRV), named the CAE (cytoplasmic accumu